A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

NCT00002168 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Indinavir sulfate
DRUG: Lamivudine
DRUG: Stavudine
DRUG: Zidovudine
DRUG: Didanosine

Sponsor

Bristol-Myers Squibb